Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

64
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
64
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

39
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
39
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

36
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
36
Uncertainty: Overview00:59

Uncertainty: Overview

535
In analytical chemistry, we often perform repetitive measurements to detect and minimize inaccuracies caused by both determinate and indeterminate errors. Despite the cares we take, the presence of random errors means that repeated measurements almost never have exactly the same magnitude. The collective difference between these measurements - observed values - and the estimated or expected value is called uncertainty. Uncertainty is conventionally written after the estimated or expected value.
535
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

237
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
237

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Spatially heterogeneous T1w/T2w ratio alterations in relapsing-remitting multiple sclerosis: associations with cognitive impairment.

Multiple sclerosis and related disorders·2026
Same author

Thermal morphing of inflatable liquid crystal elastomer domes with kirigami-enabled programmability.

Soft matter·2026
Same author

The hydra and hormetic effects in a single discrete-time overcompensation model.

Mathematical biosciences·2026
Same author

Coronary atherosclerosis: From plaque evolution and stent-biomaterial interface to rehabilitation-induced vascular remodeling.

The international journal of biochemistry & cell biology·2026
Same author

Phospholipid remodeling interplays with auxin signaling to modulate cellular reprogramming in Arabidopsis regeneration.

The Plant cell·2026
Same author

Sustainable Coexistence with Infectious Diseases: A Behavioral Feedback Model Driven by Resource Accessibility under Static-Dynamic Optimal Control.

Bulletin of mathematical biology·2026

相关实验视频

Updated: Jun 21, 2025

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.5K

随机由药物坚持驱动的HIV动态模型的不确定性量化.

Dingding Yan1, Mengqi He1, Sanyi Tang2

  • 1School of Mathematics and Statistics, Shaanxi Normal University, Xi'an, 710119, PR China.

Journal of theoretical biology
|July 5, 2024
PubMed
概括

了解药物坚持对于有效的HIV治疗至关重要. 这项研究模拟了HIV的药理动力学,将药物坚持与治疗结果联系起来,改进了个性化的抗逆转录病毒策略.

科学领域:

  • 数学生物学 数学生物学
  • 药理动力学 药理动力学
  • 免疫学 免疫学 免疫学

背景情况:

  • 艾滋病毒患者中CD4+T细胞计数和病毒载荷的高变异性使治疗疗效评估复杂化.
  • 药物坚持不佳是这种变化和治疗不确定性的潜在驱动因素.

研究的目的:

  • 开发一个动态的HIV模型,将药理动力学和药物坚持作为随机变量.
  • 量化治疗艾滋病毒治疗中药物坚持和治疗结果之间的关系.
  • 提高个性化抗逆转录病毒疗法策略的设计.

主要方法:

  • 开发了一个动态的艾滋病毒模型与药理动力学原理相结合.
  • 采用了适应性通用多项式混沌来进行随机解近似.
  • 使用蒙特卡洛采样和临床患者数据验证模型准确性.

主要成果:

  • 该模型准确地描述了艾滋病毒的动态,匹配了四名患者的临床数据.
  • 敏感性分析 (Sobol指数) 显示药物效应随机性显著影响CD4+ T细胞和病毒载荷.
  • 时间依赖的概率密度函数以理论和数值计算.

结论:

关键词:
适应性概括的多项式混乱数据拟合数据 拟合数据随机微分方程 随机微分方程索博尔指数是索博尔的指数.不确定性量化不确定性的量化.

更多相关视频

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.7K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

536

相关实验视频

Last Updated: Jun 21, 2025

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

31.5K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.7K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

536
  • 药物坚持显著影响艾滋病毒治疗疗效,影响CD4+T细胞和病毒载荷.
  • 开发的模型为解释临床数据波动提供了一个框架.
  • 这项研究有助于设计最佳的,基于个人的抗逆转录病毒策略.